Welcome to the Primary Aldosteronism Foundation

A Patient-Driven Initiative Dedicated to Advocacy, Education, and Research

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.”
Understanding of the disease remains fragmented, and it is seldom diagnosed and treated.

Although it affects millions of hypertensives, primary aldosteronism is mistakenly considered “rare.” Understanding of the disease remains fragmented, and it is seldom adequately diagnosed and treated.

We are a patient initiative created to raise awareness of the prevalence of primary aldosteronism, encourage timely diagnosis and treatment, foster accelerated research, and facilitate patient collaboration.

We help those who have, or suspect they have primary aldosteronism, navigate the road to accurate diagnosis, obtain adequate and effective treatment, stay abreast of relevant medical advances, and optimize care.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.
Whether you or someone you know have high blood pressure that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.

We serve the primary aldosteronism community worldwide and are headquartered in the US state of Arizona.

Whether you or someone you know have hypertension that is long-standing and/or difficult to control, help us support the development of adequate responses to primary aldosteronism by signing the Foundation’s Open Letter.